Millennium Management LLC Acquires New Stake in Tilray Inc (NASDAQ:TLRY)

Millennium Management LLC bought a new stake in shares of Tilray Inc (NASDAQ:TLRY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 660,834 shares of the company's stock, valued at approximately $879,000. Millennium Management LLC owned about 0.07% of Tilray as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. KBC Group NV boosted its position in Tilray by 75.9% in the fourth quarter. KBC Group NV now owns 38,332 shares of the company's stock worth $51,000 after purchasing an additional 16,539 shares during the last quarter. Newman Dignan & Sheerar Inc. lifted its position in shares of Tilray by 61.9% during the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after buying an additional 10,000 shares during the last quarter. CIBC Asset Management Inc raised its stake in shares of Tilray by 11.4% during the 4th quarter. CIBC Asset Management Inc now owns 1,011,740 shares of the company's stock valued at $1,335,000 after purchasing an additional 103,642 shares during the period. Atria Wealth Solutions Inc. raised its stake in shares of Tilray by 174.7% during the 4th quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company's stock valued at $112,000 after purchasing an additional 53,751 shares during the period. Finally, Alberta Investment Management Corp increased its stake in Tilray by 58.2% in the 4th quarter. Alberta Investment Management Corp now owns 668,800 shares of the company's stock worth $884,000 after acquiring an additional 246,000 shares during the last quarter. Hedge funds and other institutional investors own 9.35% of the company's stock.

Analyst Ratings Changes

TLRY has been the topic of a number of research analyst reports. Roth Capital restated a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler dropped their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a report on Wednesday, April 9th.

Tilray Stock Up 4.5%

Shares of NASDAQ:TLRY traded up $0.02 during trading on Friday, hitting $0.41. The stock had a trading volume of 28,643,940 shares, compared to its average volume of 28,910,851. Tilray Inc has a 12 month low of $0.37 and a 12 month high of $2.15. The company has a market capitalization of $408.23 million, a PE ratio of -1.35 and a beta of 1.83. The firm's fifty day moving average is $0.47 and its 200 day moving average is $0.85. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company had revenue of $185.78 million during the quarter, compared to the consensus estimate of $213.38 million. Analysts anticipate that Tilray Inc will post -0.2 EPS for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.